1. Home
  2. PFE vs CCIA Comparison

PFE vs CCIA Comparison

Compare PFE & CCIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFE
  • CCIA
  • Stock Information
  • Founded
  • PFE 1849
  • CCIA N/A
  • Country
  • PFE United States
  • CCIA
  • Employees
  • PFE N/A
  • CCIA N/A
  • Industry
  • PFE Biotechnology: Pharmaceutical Preparations
  • CCIA
  • Sector
  • PFE Health Care
  • CCIA
  • Exchange
  • PFE Nasdaq
  • CCIA Nasdaq
  • Market Cap
  • PFE 134.2B
  • CCIA N/A
  • IPO Year
  • PFE N/A
  • CCIA 2023
  • Fundamental
  • Price
  • PFE $23.35
  • CCIA $25.54
  • Analyst Decision
  • PFE Hold
  • CCIA
  • Analyst Count
  • PFE 14
  • CCIA 0
  • Target Price
  • PFE $29.92
  • CCIA N/A
  • AVG Volume (30 Days)
  • PFE 45.6M
  • CCIA N/A
  • Earning Date
  • PFE 04-29-2025
  • CCIA N/A
  • Dividend Yield
  • PFE 7.32%
  • CCIA N/A
  • EPS Growth
  • PFE N/A
  • CCIA N/A
  • EPS
  • PFE 1.38
  • CCIA N/A
  • Revenue
  • PFE $62,464,000,000.00
  • CCIA N/A
  • Revenue This Year
  • PFE N/A
  • CCIA N/A
  • Revenue Next Year
  • PFE N/A
  • CCIA N/A
  • P/E Ratio
  • PFE $17.02
  • CCIA N/A
  • Revenue Growth
  • PFE 11.65
  • CCIA N/A
  • 52 Week Low
  • PFE $20.92
  • CCIA N/A
  • 52 Week High
  • PFE $31.54
  • CCIA N/A
  • Technical
  • Relative Strength Index (RSI)
  • PFE 51.18
  • CCIA 53.02
  • Support Level
  • PFE $23.11
  • CCIA $25.26
  • Resistance Level
  • PFE $23.62
  • CCIA $25.59
  • Average True Range (ATR)
  • PFE 0.46
  • CCIA 0.11
  • MACD
  • PFE 0.09
  • CCIA 0.01
  • Stochastic Oscillator
  • PFE 79.48
  • CCIA 70.74

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

About CCIA Carlyle Credit Income Fund 8.75% Series A Preferred Shares due 2028

Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: